Crohn’s Disease – Intolerance to Biologic Therapy
PMG Research of DuPage Medical Group
A research study is evaluating an investigational medication for moderate to severely active Crohn’s disease for people who have an inadequate response or intolerance to biologic therapy.
This research study may be an option if you:
• Have a diagnosis of Crohn’s Disease
• Have no current diagnosis of ulcerative colitis (UC) or indeterminate colitis
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.
Qualified participants will receive all study-related care and study medication at no cost.
Patient Commitment Duration
Approximately 8 months. Subjects who complete the study and achieve clinical response may be enrolled into a long-term maintenance study.
Financial compensation may be provided for time and travel expenses.
Number of visits in study
Approximately 10 clinic visits